AMGN vs NMTC · P/E 24, rev $10.05B vs rev $2.0M
Amgen Inc (AMGN) versus Neuroone Medical Technologies Corp (NMTC) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Neuroone Medical Technologies Corp (NMTC) is a medical devices company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported NMTC revenue for 2026-06-30 was $2.0M. Net income was -$2.0M. Revenue was down 17.5% from 2026-03-31 to 2026-06-30. NMTC currently screens at market cap $35.5M.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. NMTC currently screens at market cap $35.5M.
Not investment advice. Open the AMGN and NMTC stock pages for the full models.
Not investment advice.